Pharmacological Management of Obsessive-Compulsive Disorder: A Review for Clinicians
The DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.
Abstract
Obsessive-compulsive disorder (OCD) has been treated pharmacologically with drugs that enhance availability of the neurotransmitter serotonin. This review summarizes the available literature on the pharmacological treatments of OCD. Numerous randomized controlled trials have attested to the efficacy of serotonin-reuptake inhibitors (SRIs) in treating this disorder, although a coherent model of serotonin dysfunction in OCD has not been established. Meta-analyses of randomized controlled trials have found better results with clomipramine than with other SRIs, but comparative studies have so far not replicated this finding. Aspects of the methodology in these studies that might explain this discrepancy are considered. Tolerability, side effects, dosing, and safety during pregnancy of the SRIs are discussed. Treatment of OCD with poor insight and of OCD comorbid with a tic disorder, augmentation strategies, and management of partial response to SRIs are reviewed. Finally, the available interventions for refractory OCD are considered.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mataix-Cols, D., Rauch, S. L., Manzo, P. A., Jenike, M. A., & Baer, L. (1999) · American Journal of Psychiatry · doi:10.1176/ajp.156.9.1409 · Cited by 716
McDougle, C. J., Epperson, C. N., Pelton, G. H., Wasylink, S., & Price, L. H. (2000) · Archives of General Psychiatry · doi:10.1001/archpsyc.57.8.794 · Cited by 571
Abramowitz, J. S. (1997) · Journal of Consulting and Clinical Psychology · doi:10.1037/0022-006x.65.1.44 · Cited by 490
(1988) · American Journal of Psychiatry · doi:10.1176/ajp.145.12.1521 · Cited by 301
van Balkom, A. (1994) · Clinical Psychology Review · doi:10.1016/0272-7358(94)90033-7 · Cited by 285
Behavioral versus pharmacological treatments of obsessive compulsive disorder: a meta-analysis
Kobak, K. A., Greist, J. H., Jefferson, J. W., Katzelnick, D. J., & Henk, H. J. (1998) · Psychopharmacology · doi:10.1007/s002130050558 · Cited by 276
VAN BALKOM, A. J. L. M., DE HAAN, E., VAN OPPEN, P., SPINHOVEN, P., HOOGDUIN, K. A. L., & VAN DYCK, R. (1998) · The Journal of Nervous & Mental Disease · doi:10.1097/00005053-199808000-00007 · Cited by 250
Clomipramine, Clonazepam, and Clonidine Treatment of Obsessive-Compulsive Disorder
HEWLETT, W. A., VINOGRADOV, S., & AGRAS, W. S. (1992) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-199212000-00008 · Cited by 129
Neurosurgical treatment of obsessive-compulsive disorder
Jenike, M. A. (1998) · British Journal of Psychiatry · doi:10.1192/s0007125000297936 · Cited by 129
Intranasal oxytocin in obsessive-compulsive disorder
Epperson, C. N., McDougle, C. J., & Price, L. H. (1996) · Biological Psychiatry · doi:10.1016/0006-3223(96)00120-5 · Cited by 88
Cited by
Bloch, M. H., Landeros-Weisenberger, A., Kelmendi, B., Coric, V, Bracken, M. B., & Leckman, J. F. (2006) · Molecular Psychiatry · doi:10.1038/sj.mp.4001823 · Cited by 635
Insight in obsessive compulsive disorder and body dysmorphic disorder
Eisen, J. L., Phillips, K. A., Coles, M. E., & Rasmussen, S. A. (2004) · Comprehensive Psychiatry · doi:10.1016/j.comppsych.2003.09.010 · Cited by 254
Muscatello, M. R. A., Bruno, A., Pandolfo, G., Micò, U., Scimeca, G., Romeo, V. M., Santoro, V., Settineri, S., Spina, E., & Zoccali, R. A. (2011) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0b013e31820e3db6 · Cited by 122
Insight and alexithymia in adult outpatients with obsessive–compulsive disorder
De Berardis, D., Campanella, D., Gambi, F., Sepede, G., Salini, G., Carano, A., La Rovere, R., Pelusi, L., Penna, L., Cicconetti, A., et al. (2005) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-005-0573-y · Cited by 120
Albert, U., Marazziti, D., Di Salvo, G., Solia, F., Rosso, G., & Maina, G. (2019) · Current Medicinal Chemistry · doi:10.2174/0929867325666171222163645 · Cited by 90
Metadata
- Authors
- McDonough, M., & Kennedy, N.
- Venue
- Harvard Review of Psychiatry
- Published
- 2002-01
- Volume
- 10
- Issue
- 3
- Pages
- 127-137
- ISSN
- 1067-3229 (ISSN-L)
- 1465-7309
- OpenAlex
- W2146840859
- Cited by
- 44
- References
- 11
- FWCI
- 6.83
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Pharmacological Management of Obsessive-Compulsive Disorder: A Review for Clinicians. https://app.cochat.ai/papers/10.1080/10673220216215
- The paper
- McDonough, M., & Kennedy, N. (2002). Pharmacological Management of Obsessive-Compulsive Disorder: A Review for Clinicians. Harvard Review of Psychiatry. https://doi.org/10.1080/10673220216215
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.